No more PMRT for cN1 ypN0 breast cancer?
De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study
BackgroundPrimary chemotherapy in breast cancer poses a dilemma with regard to adjuvant locoregional radiotherapy, as guidelines for locoregional radiotherapy were originally based on pathology results of primary surgery. We aimed to evaluate the oncological safety of de-escalated locoregional...
Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: TheWallnerus Tags: Radiation Oncology Source Type: forums
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Netherlands Health | Pathology | Students | Study | Universities & Medical Training